vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP (NEN). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $23.6M, roughly 1.1× NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP). Ceribell, Inc. runs the higher net margin — -54.6% vs -677.3%, a 622.8% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

New England Realty Associates Limited Partnership is a real estate investment entity that owns, operates and manages residential and commercial properties primarily across the U.S. New England region. Its core assets include multifamily apartments, mixed-use properties and small commercial spaces, serving tenants across Massachusetts, New Hampshire and adjacent states, delivering steady returns to unitholders via rental income and property value growth.

CBLL vs NEN — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.1× larger
CBLL
$24.8M
$23.6M
NEN
Higher net margin
CBLL
CBLL
622.8% more per $
CBLL
-54.6%
-677.3%
NEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
NEN
NEN
Revenue
$24.8M
$23.6M
Net Profit
$-13.5M
$-1.4M
Gross Margin
87.3%
Operating Margin
-58.9%
14.0%
Net Margin
-54.6%
-677.3%
Revenue YoY
15.7%
Net Profit YoY
-133.0%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
NEN
NEN
Q4 25
$24.8M
$23.6M
Q3 25
$22.6M
$23.7M
Q2 25
$21.2M
$21.2M
Q1 25
$20.5M
$20.7M
Q4 24
$20.4M
Q3 24
$17.2M
$20.2M
Q2 24
$20.1M
Q1 24
$19.9M
Net Profit
CBLL
CBLL
NEN
NEN
Q4 25
$-13.5M
$-1.4M
Q3 25
$-13.5M
$-521.8K
Q2 25
$-13.6M
$4.1M
Q1 25
$-12.8M
$3.8M
Q4 24
$4.2M
Q3 24
$-10.4M
$3.9M
Q2 24
$4.1M
Q1 24
$3.5M
Gross Margin
CBLL
CBLL
NEN
NEN
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Q1 24
Operating Margin
CBLL
CBLL
NEN
NEN
Q4 25
-58.9%
14.0%
Q3 25
-64.8%
20.0%
Q2 25
-70.5%
33.3%
Q1 25
-69.3%
30.1%
Q4 24
32.4%
Q3 24
-57.8%
32.0%
Q2 24
32.6%
Q1 24
28.9%
Net Margin
CBLL
CBLL
NEN
NEN
Q4 25
-54.6%
-677.3%
Q3 25
-59.6%
-2.2%
Q2 25
-64.4%
19.5%
Q1 25
-62.4%
18.3%
Q4 24
20.7%
Q3 24
-60.6%
19.3%
Q2 24
20.3%
Q1 24
17.4%
EPS (diluted)
CBLL
CBLL
NEN
NEN
Q4 25
$-0.35
Q3 25
$-0.37
Q2 25
$-0.38
Q1 25
$-0.36
Q4 24
Q3 24
$-1.85
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
NEN
NEN
Cash + ST InvestmentsLiquidity on hand
$159.3M
$26.7M
Total DebtLower is stronger
$531.0M
Stockholders' EquityBook value
$155.3M
Total Assets
$195.8M
$505.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
NEN
NEN
Q4 25
$159.3M
$26.7M
Q3 25
$168.5M
$13.4M
Q2 25
$177.4M
$16.7M
Q1 25
$182.7M
$30.9M
Q4 24
$17.6M
Q3 24
$14.1M
$15.1M
Q2 24
$13.5M
Q1 24
$28.8M
Total Debt
CBLL
CBLL
NEN
NEN
Q4 25
$531.0M
Q3 25
$514.2M
Q2 25
$514.3M
Q1 25
$407.8M
Q4 24
$408.6M
Q3 24
$409.3M
Q2 24
$410.0M
Q1 24
$410.7M
Stockholders' Equity
CBLL
CBLL
NEN
NEN
Q4 25
$155.3M
Q3 25
$164.1M
Q2 25
$172.2M
Q1 25
$180.9M
Q4 24
Q3 24
$-136.0M
Q2 24
Q1 24
Total Assets
CBLL
CBLL
NEN
NEN
Q4 25
$195.8M
$505.3M
Q3 25
$199.5M
$492.9M
Q2 25
$207.7M
$494.8M
Q1 25
$213.5M
$385.2M
Q4 24
$393.5M
Q3 24
$47.1M
$387.4M
Q2 24
$383.7M
Q1 24
$381.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
NEN
NEN
Operating Cash FlowLast quarter
$-10.8M
$27.7M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
NEN
NEN
Q4 25
$-10.8M
$27.7M
Q3 25
$-11.1M
$2.3M
Q2 25
$-7.5M
$12.5M
Q1 25
$-11.4M
$5.5M
Q4 24
$31.9M
Q3 24
$8.5M
Q2 24
$5.4M
Q1 24
$6.1M
Free Cash Flow
CBLL
CBLL
NEN
NEN
Q4 25
$-11.0M
Q3 25
$-11.5M
Q2 25
$-7.6M
Q1 25
$-11.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CBLL
CBLL
NEN
NEN
Q4 25
-44.2%
Q3 25
-50.8%
Q2 25
-35.9%
Q1 25
-56.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CBLL
CBLL
NEN
NEN
Q4 25
0.7%
Q3 25
1.6%
Q2 25
0.3%
Q1 25
0.7%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
CBLL
CBLL
NEN
NEN
Q4 25
Q3 25
Q2 25
3.02×
Q1 25
1.44×
Q4 24
7.57×
Q3 24
2.17×
Q2 24
1.32×
Q1 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

NEN
NEN

Segment breakdown not available.

Related Comparisons